Bangalore, Mar 23 (ANI/Business Wire India): Syngene International, a subsidiary of Indian biotechnology major, BIOCON Ltd, and Bristol-Myers Squibb Company announced today the opening of a fully dedicated research and development facility for Bristol-Myers Squibb in Biocon Park, Bangalore.
Sourse: More Info
Monday, March 23, 2009
Bristol-Myers Squibb, Biocon's Syngene open new R and D facility at Biocon Park
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment